重塑呼吸系统护理:在喘中吸入药物治疗的潜在进展
Boudewijn J H Dierick1,2,3, Amber A Eikholt1,2, Susanne J van de Hei1,2
1Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Expert opinion on pharmacotherapy
|August 5, 2024
概括
创新的吸入疗法对于失控喘至关重要. 进步包括数字吸入器用于粘附,环保推进剂和针对严重喘表型的新生物药,正在调查吸入途径.
科学领域:
- 肺病学和呼吸系统医学
- 药物治疗和药物输送
- 数字健康和医疗技术数字化
背景情况:
- 全球有3.58亿人患有喘,尽管目前有治疗方法,但许多患者患有无法控制的症状.
- 现有的药理和非药理疗法在很大一部分患者中具有有限的疗效.
- 需要创新的治疗策略来改善喘管理和患者的治疗结果.
研究的目的:
- 提供吸入性喘治疗近期进展的概述.
- 探索数字吸入器,环保吸入器技术和新型吸入疗法方面的创新.
- 讨论未来喘药物治疗的新兴目标和交付方法.
主要方法:
- 使用PubMed数据库进行了半结构化的文献搜索.
- 该审查侧重于已发表的吸入性喘治疗的研究和开发管道.
- 研究的重点领域包括数字健康整合,推进剂技术和新生物剂.
主要成果:
- 数字吸入器通过电子提醒和技术监控来增强药物坚持和喘控制.
- 开发环保推进剂 (HFA-152a,HFO-1234ze) 的目标是到2025年减少计量剂量吸入器对环境的影响.
- 新型生物疗法 (抗IgE,抗IL5,抗IL4/13,抗TSLP) 对严重喘表型有前途,吸入治疗是积极研究的领域.
结论:
- 数字和环保的吸入器在优化吸入性喘治疗方面取得了重大进展.
- 新的吸入生物药物和其他向治疗方法为治疗严重和不耐性喘提供了新的途径.
- 对于新兴的吸入疗法,如抗IL-33/ST2生物制剂和JAK抑制剂,需要进一步的研究和临床验证.
相关概念视频
01:23Inhaled Medications
246
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
246
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
243
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
243
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
232
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
232
01:24Antiasthma Drugs: Methylxanthines
213
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
213